Joint hypermobility syndrome in rheumatology
https://doi.org/10.14412/1996-7012-2017-2-68-74
Abstract
Joint hypermobility syndrome (JHS) is a disease characterized by symptoms of locomotor system involvement in the absence of obvious systemic rheumatic diseases (RDs). JHS accompanied by the symptomatology of RDs should be distinguished from isolated joint hypermobility, in which there are no complaints even in cases of its generalized manifestations and the patients feel virtually healthy. The paper provides an overview of the literature on the JHS. It gives diagnostic criteria for JHS (the Brighton criteria encompasses the Beighton score) and the clinical manifestation of damages to the locomotor apparatus, visceral organs, and skin in this syndrome. Autonomic nervous system dysfunction as a possible manifestation of JHS and its impact on the daily life of patients are discussed. Attention is paid to the prevention and treatment of JHS.
About the Author
A. M. Satybaldyev
V.A.Nasonova Research Institute of Rheumatology, Moscow
Russian Federation
Russian Federation
References
1. Grahame R. The hypermobility syndrome. Review article. Ann Rheum Dis. 1990 Mar;49(3):199-200.
2. Jacobs JW, da Silva JA. Hypermobility syndromes from the clinician’s perspective: an overview. Acta Reumatol Port. 2014 Apr-Jun;39(2):124-36.
3. Kirk JH, Ansell BA, Bywaters EG. The hypermobility syndrome. Ann Rheum Dis. 1967 Sep;26(5):419-25.
4. Malfait F, Hakim AJ, De Paepe A, Grahame R. The genetic basis of the joint hypermobility syndromes. Rheumatology (Oxford). 2006 May;45(5):502-7. Epub 2006 Jan 17. doi: 10.1093/rheumatology/kei268
5. Seckin U, Sonel Tur B, Yilmaz O, et al. The prevalence of joint hypermobility among high school students. Rheumatol Int. 2005 May;25(4):260-3. Epub 2004 Jan 24.
6. Engelbert R, Uiterwaal C, Van de Putte E, et al. Pediatric generalized joint hypomobility and musculoskeletal complaints: a new entity? Clinical, biochemical, and osseal characteristics. Pediatrics. 2004 Apr; 113(4):714-9.
7. Everman DB, Robin NH. Hypermobility syndrome. Pediatr Rev. 1998 Apr;19(4):111-7.
8. Finsterbush A, Pogrund H. The hypermobility syndrome. Clin Orthop Relat Res. 1982 Aug;(168):124-7.
9. Larsson LG, Baum J, Mudholkar GS, Kollia GD. Benefits and disadvantages of joint hypermobility among musicians. N Engl J Med. 1993 Oct 7;329(15):1079-82.
10. Larsson LG, Baum J, Mudholkar GS. Hypermobility features and differential incidence between the sexes. Arthritis Rheum. 1987 Dec;30(12):1426-30.
11. Grahame R. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol. 2000 Jul;27(7):1777-9.
12. Hakim AJ, Cherkas LF, Grahame R, et al. The genetic epidemiology of joint hypermobility: a population study of female twins. Arthritis Rheum. 2004 Aug;50(8):2640-4.
13. Scheper MC, de Vries JE, Verbunt J, Engelbert RH. Chronic pain in hypermobility syndrome and Ehlers–Danlos syndrome (hypermobility type): it is a challenge. J Pain Res. 2015 Aug 20;8:591-601. doi: 10.2147/JPR. S64251. eCollection 2015.
14. Bulbena A, Duro JC, Porta M, et al. Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol. 1992 Jan; 19(1):115-22.
15. Biro F, Gewanter HL, Baum J. The hypermobility syndrome. Pediatrics. 1983 Nov;72(5):701-6.
16. Gedalia A, Brewer EJ Jr. Joint hypermobility in pediatric practice – a review. J Rheumatol. 1993 Feb;20(2):371-4.
17. de Arocena IJ, Casas OI, Ortiz LB. Laxitud articular: prevalencia y relacion con dolor musculosqueletico. Joint hypermobility: prevalence and relationship with musculoskeletal pain. An Pediatr (Barc). 2004 Aug;61(2):162-6.
18. Bridges AJ, Smith E, Reid J. Joint hypermobility in adults referred to rheumatology clinics. Ann Rheum Dis. 1992 Jun;51(6):793-6.
19. Kuivaniemi H, Tromp G, Prockop DJ Genetic causes of aortic aneurysms. Unlearning at least part of what the textbooks say. J Clin Invest. 1991 Nov;88(5):1441-4.
20. Carter C, Wilkinson J. Persistent joint laxity and congenital dislocation of the hip. J Bone Joint Surg Br. 1964 Feb;46:40-5.
21. Simpson MR. Benign Joint Hypermobility Syndrome: Evaluation, Diagnosis, and Management. J Am Osteopath Assoc. 2006 Sep;106(9):531-6.
22. Beighton P, Solomon L, Soskolne CL. Articular mobility in an African population. Ann Rheum Dis. 1973 Sep;32(5):413-8.
23. Remvig L, Engelbert RH, Berglund B, et al. Need for a consensus on the methods by which to measure joint mobility and the definition of norms for hypermobility that reflect age, gender and ethnic-dependent variation: is revision of criteria for joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type indicated? Rheumatology (Oxford). 2011 Jun;50(6):1169-71. doi: 10.1093/rheumatology/ker140. Epub 2011 Apr 10.
24. Klemp P, Williams M, Stansfield A. Articular mobility in Maori and European New Zealanders. Rheumatology (Oxford). 2002 May;41(5):554-7.
25. Colombi M, Dordoni C, Chiarelli N, Ritelli M. Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet C Semin Med Genet. 2015 Mar;169C(1):6-22. doi: 10.1002/ajmg.c.31429.
26. Groth KA, Hove H, Kyhl K, et al. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis. 2015 Dec 2;10:153. doi: 10.1186/s13023- 015-0369-8.
27. Беленький АГ. Генерализованная гипермобильность суставов и другие соединительнотканные синдромы. Научно-практическая ревматология. 2001;39(4): 40-8. [Belen'kii AG. Generalized hypermobility of the joints and other connective tissue syndromes. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2001;39(4):40-8. (In Russ.)].
28. Шостак НА, Правдюк НГ. Гипермобильный синдром: клинические проявления, дифференциальный диагноз, подходы к терапии. Рациональная фармакотерапия в кардиологии. 2008;(3):70-5. [Shostak NA, Pravdyuk NG. Hypermobile syndrome: clinical manifestations, differential diagnosis, approaches to therapy. Ratsional'naya farmakoterapiya v kardiologii. 2008;(3):70-5. (In Russ.)].
29. Bravo JF, Wolff C. Clinical study of hereditary disorders of connective tissues in a Chilean population. Arthritis Rheum. 2006 Feb;54(2):515-23.
30. Folci M, Capsoni F. Arthralgias, fatigue, paresthesias and visceral pain: can joint hypermobility solve the puzzle? A case report. BMC Musculoskelet Disord. 2016 Feb 4;17:58. doi: 10.1186/s12891-016-0905-2.
31. Hakim AJ, Grahame R. Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction? Rheumatology (Oxford). 2004 Sep;43(9):1194-5.
32. Гордон ИБ, Рассохин ВМ, Никитина ТН и др. Конституциональная (генетически обусловленная) вегетативная дистония и соединительнотканная дисплазия при идиопатическом пролапсе митрального клапана. Кардиология. 1984;(1):63-7. [Gordon IB, Rassokhin VM, Nikitina TN, et al. Constitutional (genetically determined) vegetative dystonia and connective tissue dysplasia in idiopathic mitral valve prolapse. Kardiologiya. 1984;(1):63-7. (In Russ.)].
33. Gazit Y, Nahir M, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. 2003 Jul;115(1):33-40.
34. Rowe PC, Barron DF, Calkins H, et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers–Danlos syndrome. J Pediatr. 1999 Oct;135(4):494-9.
35. Gerrity TR, Bates J, Bell DS, et al . Chronic fatigue syndrome: what role does the autonomic nervous system play in the pathophysiology of this complex illness? Neuroimmunomodulation. 2002-2003; 10(3):134-41.
36. Terry RH, Palmer ST, Rimes KA, et al . Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care. Fam Pract. 2015 Jun;32(3):354-8. doi: 10.1093/fampra/cmv026. Epub 2015 Apr 24.
37. Bury M. Meaning at risk: the experience of arthritis. In: Anderson R, Bury M, editors. Living with Chronic Illness. The Experience of Patients and their Families. London: Unwin Hyman;1988. P. 89–116.
38. Всероссийское научное общество кардиологов. Наследственные нарушения соединительной ткани. Москва; 2012. 76 с. [All-Russian scientific society of cardiologists. Nasledstvennye narusheniya soedinitel'noi tkani [Hereditary disorders of connective tissue]. Moscow; 2012. 76 p.]
39. Strunk RG, Pfefer MT, Dube D. Multimodal chiropractic care of pain and disability for a patient diagnosed with benign joint hypermobility syndrome: a case report. J Chiropr Med. 2014 Mar;13(1):35-42. doi: 10.1016/j.jcm.2014.01.009.
40. Zuppiroli A, Rinaldi M, Kramer-Fox R, et al. Natural history of mitral valve prolapse. Am J Cardiol. 1995 May 15;75(15):1028-32.
41. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol. 1994 Aug 15; 74(4):374-80.
42. Fontana ME, Sparks EA, Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol. 1991 May;16(5):309-75.
43. Schaal SF. Ventricular arrhythmias in patients with mitral valve prolapse. Cardiovasc Clin. 1992;22(1):307-16.
Review
For citations:
Satybaldyev AM. Joint hypermobility syndrome in rheumatology. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2017;11(2):68-74. (In Russ.) https://doi.org/10.14412/1996-7012-2017-2-68-74
Views:
3946
Email this article 